ENTITY mFlusiva

mFlusiva

PulseAugur coverage of mFlusiva — every cluster mentioning mFlusiva across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

TOPICS

TIMELINE

2026-08-06 product_launch The FDA approved Moderna's mRNA flu vaccine, mFlusiva, for adults aged 50 and over. source

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

RESEARCH · CL_185629 · Aug 6 · 08:52

FDA approves Moderna's mRNA flu vaccine after initial review refusal

The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, named mFlusiva (mRNA-1010), for adults aged 50 and over. This approval follows an initial refusal by the FDA to review the vacci…